Feb 25 (Reuters) - Immuron Ltd IMC.AX:
IMMURON REPORTS HY26 RESULTS AND STRATEGIC RESET
IMMURON LTD: TAKEN A STRATEGIC DECISION TO PURSUE PARTNERSHIPS TO FUND PROGRESS OF TRAVELAN AND IMM-529 CLINICAL PROGRAMS
Source text: ID:nGNX5F39D5
Further company coverage: IMC.AX
((Reuters.Briefs@thomsonreuters.com;))